Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies a...(ombination Products 103 TABLE 35 MARK...),Health

TABLE 35 MARKETED OTC ANTACID PRODUCTS 103

TABLE 35 (CONTINUED) 104

MARKET SIZE AND GROWTH 104

TABLE 36 GLOBAL OTC ANTACID MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 104

FIGURE 20 GLOBAL OTC ANTACID MARKET BY REGION, 2007-2014 ($ MILLIONS) 105

COMPETITIVE STRUCTURE AND MARKET SHARE 105

TABLE 37 GLOBAL OTC ANTACID REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) 106

FIGURE 21 GLOBAL OTC ANTACID MARKET SHARE BY MANUFACTURER, 2009 (%) 106

LOCALLY ACTING ANTIDIARRHEALS 106

ADSORBENTS 107

INTESTINAL FLORA MODIFIERS 108

TABLE 38 MARKETED OTC ANTIDIARRHEAL PRODUCTS 108

MARKET SIZE AND GROWTH 108

TABLE 39 GLOBAL OTC ANTIDIARRHEALS MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 109

FIGURE 22 GLOBAL OTC ANTIDIARRHEALS MARKET BY REGION, 2007-2014 ($ MILLIONS) 109

COMPETITIVE STRUCTURE AND MARKET SHARE 110

TABLE 40 GLOBAL OTC ANTIDIARRHEALS REVENUES BY MANUFACTURER, 2009 ($ MILLIONS/%) 110

FIGURE 23 GLOBAL OTC ANTIDIARRHEALS MARKET SHARE BY MANUFACTURER, 2009 (%) 110

H2 INHIBITORS 111

H2 INHIBITORS (CONTINUED) 112

H2 INHIBITORS (CONTINUED) 113

TABLE 41 MARKETED OTC H2 INHIBITORS PRODUCTS 114

MARKET SIZE AND GROWTH 114

TABLE 42 GLOBAL OTC H2 INHIBITOR MARKET BY REGION, THROUGH 2014 ($ MILLIONS) 114

FIGURE 24 GLOBAL OTC H2 INHIBITOR MARKET BY REGION, 2007-2014 ($ MILLIONS) 115

COMPETITIVE STRUCTURE AND MARKET SHARE 115

TABLE 43 GLOBAL OTC H2 INHIBITOR REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) 116

FIGURE 25 GLOBAL OTC H2 INHIBITOR MARKET SHARE BY MANUFACTURER, 2009 (%) 116

PROTON PUMP INHIBITORS 116

OMEPRAZOLE (PRILOSEC, PROCTER & GAMBLE) 116

TABLE 44 MARKETED OTC PROTON PUMP INHIBITOR
'/>"/>